414 related articles for article (PubMed ID: 34073629)
1. The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.
Tsai CY; Hsieh SC; Liu CW; Lu CH; Liao HT; Chen MH; Li KJ; Wu CH; Shen CY; Kuo YM; Yu CL
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073629
[TBL] [Abstract][Full Text] [Related]
2. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
3. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies.
Bashar SJ; Holmes CL; Shelef MA
Front Immunol; 2024; 15():1167362. PubMed ID: 38476240
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling.
Miao CG; Yang YY; He X; Li XF; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Cell Signal; 2013 Oct; 25(10):2069-78. PubMed ID: 23602936
[TBL] [Abstract][Full Text] [Related]
5. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
7. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
Romero V; Darrah E; Andrade F
Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between B cells and neutrophils in rheumatoid arthritis.
Karmakar U; Vermeren S
Immunology; 2021 Dec; 164(4):689-700. PubMed ID: 34478165
[TBL] [Abstract][Full Text] [Related]
9. The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Cabral AR; Llorente L
Clin Rheumatol; 2016 Jan; 35(1):55-61. PubMed ID: 26255191
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of non-coding RNAs in Rheumatoid arthritis.
Taheri M; Eghtedarian R; Dinger ME; Ghafouri-Fard S
Biomed Pharmacother; 2020 Oct; 130():110617. PubMed ID: 32781359
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
[TBL] [Abstract][Full Text] [Related]
12. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
13. [Peptidylarginine deiminase type4 (PADI4) role in immune system].
Seri Y; Shoda H; Matsumoto I; Sumida T; Fujio K; Yamamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):154-9. PubMed ID: 24974927
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis.
Bi X; Guo XH; Mo BY; Wang ML; Luo XQ; Chen YX; Liu F; Olsen N; Pan YF; Zheng SG
EBioMedicine; 2019 Dec; 50():408-420. PubMed ID: 31791845
[TBL] [Abstract][Full Text] [Related]
15. Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis.
Mousavi MJ; Jamshidi A; Chopra A; Aslani S; Akhlaghi M; Mahmoudi M
J Cell Physiol; 2018 Jan; 234(1):335-347. PubMed ID: 30069877
[TBL] [Abstract][Full Text] [Related]
16. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
17. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
Front Immunol; 2018; 9():2696. PubMed ID: 30515171
[No Abstract] [Full Text] [Related]
19. Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease.
Karami J; Aslani S; Tahmasebi MN; Mousavi MJ; Sharafat Vaziri A; Jamshidi A; Farhadi E; Mahmoudi M
Immunol Cell Biol; 2020 Mar; 98(3):171-186. PubMed ID: 31856314
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]